Findings that MacEq had "serious compliance deficiencies" are not surprising. I again say, what I stated a month to two ago re Macquaries BIZARRE comments about the structuring of the MSB/Teva Ph3 cardio trial - can Macquaries advise us all please as to their recognised expertise regards such trials, including their medical qualifications and experience etc?
MSB has had an excellent start to 2013 and I hope better is still to come.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.41 |
Change
0.620(34.6%) |
Mkt cap ! $3.161B | |||
| Open | High | Low | Value | Volume |
| $1.90 | $2.48 | $1.90 | $45.28M | 20.10M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 167 | $2.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.42 | 101878 | 22 |
View Market Depth
| Last trade - 14.29pm 18/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |